RBC-Pharmeco is a project launched to create an innovative device for automatic supply of drugs into red blood cells to therefore increase the efficacy and safety profile of such drugs.
FarmaMondo is the representative office in Russia of an international pharmaceutical distributor FarmaMondo, headquartered in Switzerland.
In Russia, FarmaMondo was registered at the end of 2018. The company focused on the supply of drugs for oncological and orphan diseases.
FarmaMondo partners with foreign biotech manufacturing companies that are not represented in the Russian market.
Currently, the Swiss FarmaMondo SA owns 30 per cent of the Russian FarmaMondo, another 38 per cent belongs to the German BioMedica Holding GmbH.
In TECHNOPOLIS Moscow, the PharmEco Group has kicked off the project on setting up an import replacement production of biotech drugs called BIOJET.
Biojet will be engaged in design and production of biotechnological medications based on monoclonal antibodies in full cycle right from the manufacture of the active pharmaceutical ingredient.